Ace Therapeutics Releases Proteomic Analysis Services for Glaucoma Research
Ace Therapeutics, an integrated service provider for glaucoma research, is proud to announce the release of its proteomic analysis services for glaucoma research. These cutting-edge analysis services are expected to revolutionize the way researchers approach the study of glaucoma, a leading cause of irreversible blindness worldwide.